Cargando…
Utilization of Site-Specific Recombination in Biopharmaceutical Production
Mammalian expression systems, due to their capacity in post-translational modification, are preferred systems for biopharmaceutical protein production. Several recombinant protein systems have been introduced to the market, most of which are under clinical development. In spite of significant improv...
Autores principales: | Ahmadi, Maryam, Damavandi, Narges, Akbari, Mohammad Reza, Davami, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute of Iran
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726886/ https://www.ncbi.nlm.nih.gov/pubmed/26602035 http://dx.doi.org/10.7508/ibj.2016.02.001 |
Ejemplares similares
-
Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020) -
Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae
por: Barolo, Lorenzo, et al.
Publicado: (2020) -
A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals
por: Owczarek, B., et al.
Publicado: (2019) -
Cyberbiosecurity for Biopharmaceutical Products
por: Mantle, Jennifer L., et al.
Publicado: (2019) -
Biopharmaceuticals from microorganisms: from production to purification
por: Jozala, Angela Faustino, et al.
Publicado: (2016)